Wat betekent 'helder'?
Het dier draagt de mutatie niet. Het zal de ziekte niet ontwikkelen en zal het niet doorgeven.
Von Willebrand Disease III (vWDIII) in Scottish Terriers is a serious inherited bleeding disorder caused by a deficiency of von Willebrand factor. DNA testing for vWDIII helps identify carriers and affected dogs, enabling responsible breeding decisions to reduce disease prevalence. Early detection through genetic screening ensures timely management and improves the quality of life for Scottish Terriers. This DNA test is essential for breeders and owners aiming to maintain healthy blood clotting function in their dogs. By using vWDIII DNA testing, you can prevent the transmission of this life-threatening condition. Protect your Scottish Terrier’s health with accurate genetic testing today. Stay informed and promote responsible breeding practices with vWDIII DNA tests.
Von Willebrand Disease Type III (vWDIII) is a severe bleeding disorder found in Scottish Terriers. It is caused by a deficiency of von Willebrand factor, a protein essential for blood clotting. DNA testing can identify carriers and affected dogs, helping breeders make informed decisions. Early detection through genetic screening reduces the risk of passing the disease to offspring. Responsible breeding practices improve the overall health of the Scottish Terrier population.
Deze DNA-test is inbegrepen vanaf ons pakket Basic — en maakt ook deel uit van de pakketten Basic, Standard, Advanced, Complete.
Bekijk DNA Testpakketten →Von Willebrand Disease (vWD) is a genetic blood disorder that affects the ability of blood to clot properly. In Scottish Terriers, vWD Type III is a particularly severe form of the disease, characterized by a significant deficiency of von Willebrand factor (vWF), a protein critical for platelet adhesion during the blood clotting process. This deficiency can lead to increased bleeding tendencies, making it vital for owners and breeders to have a comprehensive understanding of the condition.
Scottish Terriers affected by vWDIII may exhibit various clinical signs, which can vary in severity. Common symptoms include excessive bleeding from minor cuts or injuries, prolonged bleeding after surgery or dental procedures, and spontaneous bleeding episodes such as nosebleeds or bruising. In some cases, affected dogs may also show signs of anemia due to chronic blood loss, which can manifest as lethargy, weakness, and pale gums.
The diagnosis of vWDIII in Scottish Terriers typically involves a combination of clinical evaluation and laboratory testing. A veterinarian may first suspect the condition based on the dog's clinical history and bleeding tendencies. Subsequently, specific tests can be conducted to measure the levels of von Willebrand factor in the blood, confirming the diagnosis of vWD Type III.
Managing Von Willebrand Disease III in Scottish Terriers focuses on minimizing bleeding risks and addressing any episodes of excessive bleeding. Treatment options may include the use of desmopressin, a medication that can temporarily increase the levels of von Willebrand factor in the bloodstream. Additionally, owners are advised to take precautions to avoid situations that may lead to injury or bleeding, such as avoiding rough play or high-risk activities. In severe cases, blood transfusions may be necessary to manage acute bleeding episodes.
Genetic testing plays a crucial role in managing Von Willebrand Disease III in Scottish Terriers. By identifying carriers of the vWD gene, breeders can make informed decisions to minimize the risk of producing affected puppies. Responsible breeding practices, including screening potential breeding dogs for the vWD gene, can significantly reduce the prevalence of this condition in future generations.
Von Willebrand Disease III is a serious condition in Scottish Terriers that requires awareness and proactive management. By understanding the signs, diagnosis, and treatment options available, owners can better care for their dogs and contribute to responsible breeding practices that help reduce the incidence of this hereditary disorder.
Het dier draagt de mutatie niet. Het zal de ziekte niet ontwikkelen en zal het niet doorgeven.
Nee. Het dier is over het algemeen gezond, maar kan de mutatie doorgeven aan zijn dier nakomelingen.
Het bevat twee gemuteerde exemplaren. Klinische symptomen worden verwacht, afhankelijk van de ziekte. Er mag niet mee worden gefokt.
Sommige ziekten zijn geslachtsgebonden, dus de uiting ervan varieert afhankelijk van de ziekte geslacht van het dier.
This DNA test detects the mutation associated with Von Willebrand Disease Iii In Scottish Terrier (vWDIII-ST) in order to identify clear, carrier, or at-risk animals.
DNA-testen helpen fokkers om veiligere paringen te plannen en het risico op het overdragen van de mutatie aan nakomelingen te verminderen.
De voor deze test gerapporteerde overervingsmodus is autosomaal recessief.
This test analyses the mutation VWF c.255del.
Niet noodzakelijkerwijs. De interpretatie hangt af van het overervingspatroon en het resulterende genotype.
Venta P J, Li J, YuzbasiyanGurkan V, Brewer G J, Schall W D. Mutation causing von Willebrand's disease in Scottish Terriers. J Vet Intern Med. 2000 Jan-Feb;14(1):10-9. doi: 10.1892/0891-6640(2000)0142.3.co;2.
Jouw privacy, jouw keuze
Wij gebruiken essentiële cookies om de website te laten functioneren. Optionele cookies (zoals aanbieders van ingebedde inhoud) zijn standaard uitgeschakeld en worden alleen ingeschakeld als u hiermee akkoord gaat. U kunt uw keuze op elk moment wijzigen via de knop “Cookies”.
Vereist voor kernfunctionaliteiten en beveiliging. Altijd ingeschakeld.
Verbeterd functies zoals het opslaan van voorkeuren of niet-advertentie embeds.
Helpt ons om het gebruik van de site te begrijpen. Standaard uitgeschakeld.
Advertentie/volgen over sites (enkele video/kaarten insluitingen). Standaard uitgeschakeld.